Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Nascimbeni

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Journal of Clinical Medicine|February 24, 2024
Metabolic Disorders in Liver Transplant Recipients: The State of the ArtFilippo Gabrielli, Lucia Golfieri, Fabio Nascimbeni, et al.
Advances in Therapy|February 28, 2016
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in HumansStefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, et al.
Expert Review of Gastroenterology & Hepatology|February 20, 2015
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complicationsStefano Ballestri, Dante Romagnoli, Fabio Nascimbeni, et al.
Clinical Biochemistry|May 7, 2026
Direct serum biomarkers of liver fibrosis in metabolic dysfunction-associated steatotic liver disease: A scoping reviewValentina Pecoraro, Fabio Nascimbeni, Filippo Gabrielli, et al.
Advances in Therapy|May 21, 2017
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular RiskStefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, et al.
Journal of Clinical Medicine|October 13, 2021
Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Peripheral Diabetic Polyneuropathy: A Systematic Review and Meta-AnalysisCarla Greco, Fabio Nascimbeni, Francesca Carubbi, et al.
Diagnostics (Basel, Switzerland)|March 13, 2025
Diagnostic Accuracy of Golgi Protein 73 (GP73) for Liver Fibrosis Staging in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Scoping Review and Cohort StudyValentina Pecoraro, Fabio Nascimbeni, Michela Cuccorese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 15, 2020
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologistFrancesca Carubbi, Maria Domenica Cappellini, Silvia Fargion, et al.
International Journal of Molecular Sciences|March 24, 2016
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightStefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 9, 2019
Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?Amedeo Lonardo, Stefano Ballestri, Alessandro Mantovani, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|February 24, 2024
Metabolic Disorders in Liver Transplant Recipients: The State of the ArtFilippo Gabrielli, Lucia Golfieri, Fabio Nascimbeni, et al.
Advances in Therapy|February 28, 2016
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in HumansStefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, et al.
Expert Review of Gastroenterology & Hepatology|February 20, 2015
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complicationsStefano Ballestri, Dante Romagnoli, Fabio Nascimbeni, et al.
Clinical Biochemistry|May 7, 2026
Direct serum biomarkers of liver fibrosis in metabolic dysfunction-associated steatotic liver disease: A scoping reviewValentina Pecoraro, Fabio Nascimbeni, Filippo Gabrielli, et al.
Advances in Therapy|May 21, 2017
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular RiskStefano Ballestri, Fabio Nascimbeni, Enrica Baldelli, et al.
Journal of Clinical Medicine|October 13, 2021
Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Peripheral Diabetic Polyneuropathy: A Systematic Review and Meta-AnalysisCarla Greco, Fabio Nascimbeni, Francesca Carubbi, et al.
Diagnostics (Basel, Switzerland)|March 13, 2025
Diagnostic Accuracy of Golgi Protein 73 (GP73) for Liver Fibrosis Staging in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Scoping Review and Cohort StudyValentina Pecoraro, Fabio Nascimbeni, Michela Cuccorese, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 15, 2020
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologistFrancesca Carubbi, Maria Domenica Cappellini, Silvia Fargion, et al.
International Journal of Molecular Sciences|March 24, 2016
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightStefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 9, 2019
Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity?Amedeo Lonardo, Stefano Ballestri, Alessandro Mantovani, et al.
Pageof 5